{"SPADE_UN_16254": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_16254", "Peptide Name": "Oncocin Onc112 analog b", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "VXKPPYLPRPRWPRRIYNR", "Sequence Length": 19, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:SH-SY5Y (<10% Cytotoxicity=600 µg/ml); HepG2 (10% Cytotoxicity=600 µg/ml); HeLa  (40% Cytotoxicity=601 µg/ml)", "Hemolytic Activity": "Not available", "Cytotoxicity": "HEK293:50-60% Cytotoxicity=600 µg/ml", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "Mix", "Structure Description": "Not found", "Formula": "C99H144N28O17", "Mass": 242962, "PI": 11.47, "Net Charge": 4, "Hydrophobicity": -1.047, "Half Life": "Mammalian:100 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Optimization of oncocin for antibacterial activity using a SPOT synthesis approach extending the pathogen spectrum to Staphylococcus aureus", "Pubmed ID": "26334348", "Reference": "Amino Acids. 2016 Jan;48(1)269-80.", "Author": "Knappe D, Ruden S, Langanke S, Tikkoo T, Ritzer J, Mikut R, Martin LL, Hoffmann R, Hilpert K.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=26334348"}], "Frequent Amino Acids": "PRY", "Absent Amino Acids": "ACDEFGHMOQSTU", "Basic Residues": 6, "Acidic Residues": 0, "Hydrophobic Residues": 11, "Polar Residues": 10, "Positive Residues": 6, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_16247", "Similarity": 1.0, "Sequence": "VKPPYLPRPRWPRIYN"}, {"SPADE_ID": "SPADE_UN_16253", "Similarity": 0.9444444444444444, "Sequence": "VRKPPYLPRPRWPRRIYNR"}, {"SPADE_ID": "SPADE_UN_16255", "Similarity": 0.9444444444444444, "Sequence": "VRKPPYLPRPRWPRRIYNR"}]}}}